SCHEMBL7930092

SCHEMBL7930092

CCC(CC)C[C@@](CC(C)C)(C(=O)NN)C(C/C=C/c1ccccc1)C(=O)NOCc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSC P53634 1/20 0.37
HTR2A P28223 3/20 0.36
HDAC3 O15379 2/20 0.36
HDAC4 P56524 2/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC7 Q8WUI4 2/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC10 Q969S8 2/20 0.36
HDAC11 Q96DB2 2/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC9 Q9UKV0 2/20 0.36
HDAC5 Q9UQL6 2/20 0.36
GHSR Q92847 2/20 0.34
PSMB5 P28074 1/20 0.34
MASP2 O00187 1/20 0.34
CTSS P25774 1/20 0.33
MME P08473 1/20 0.33
ACE P12821 1/20 0.33
CPA1 P15085 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7930087 1.00 CTSC (0.37) CTSCHTR2AHDAC3HDAC4HDAC1
SCHEMBL7930090 1.00 CTSC (0.37) CTSCHTR2AHDAC3HDAC4HDAC1
SCHEMBL7930095 1.00 CTSC (0.37) CTSCHTR2AHDAC3HDAC4HDAC1
SCHEMBL7819028 0.77 GHSR (0.36) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL7823165 0.77 MAPT (0.39) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6982254 0.73 HDAC3 (0.37) CTSCHTR2AHDAC3HDAC4HDAC1
SCHEMBL6984118 0.71 ADAM17 (0.45) CTSCHTR2APSMB5MMP1MMP2
SCHEMBL7931077 0.69 ADAM17 (0.34) CTSCHTR2AMASP2
SCHEMBL6984117 0.68 ACE (0.38) ACEMMP1MMP2MMP3
SCHEMBL6982257 0.67 ADAM17 (0.45) CTSCHTR2APSMB5MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed